HANGZHOU ALLTEST BIOTECH CO.,LTD. — Investor Relations & Filings
About HANGZHOU ALLTEST BIOTECH CO.,LTD.
Hangzhou AllTest Biotech Co., Ltd. specializes in the research, development, and manufacturing of advanced in vitro diagnostic (IVD) solutions. The company offers a comprehensive portfolio of rapid diagnostic test kits utilizing lateral flow immunoassay technology. Key product categories include infectious disease diagnostics, drug of abuse testing, oncology and cardiac markers, fertility tests, and veterinary diagnostics. AllTest Biotech focuses on providing high-quality, reliable, and easy-to-use testing solutions for clinical laboratories, hospitals, and point-of-care settings globally. The organization maintains rigorous quality management systems, holding international certifications such as ISO 13485, with many products receiving CE marking and FDA clearance. By leveraging innovative R&D and large-scale production capabilities, the company delivers cost-effective diagnostic tools designed to improve healthcare outcomes through early detection and monitoring.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年年度股东会会议资料 | 2026-04-27 | Chinese | |
| 关于杭州奥泰生物技术股份有限公司非经营性资金占用及其他关联资金往来的专项说明（更正） | 2026-04-20 | Chinese | |
| 2025年度独立董事述职报告（陈善基） | 2026-04-19 | Chinese | |
| 关于召开2025年年度暨2026年第一季度业绩说明会的公告 | 2026-04-19 | Chinese | |
| 2025年度董事会审计委员会履职报告 | 2026-04-19 | Chinese | |
| 关于2025年度利润分配方案及2026年中期分红规划的公告 | 2026-04-19 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39155345 | 2025年年度股东会会议资料 | 2026-04-27 | Chinese | ||
| 39155334 | 关于杭州奥泰生物技术股份有限公司非经营性资金占用及其他关联资金往来的专项说明（更正） | 2026-04-20 | Chinese | ||
| 39155054 | 2025年度独立董事述职报告（陈善基） | 2026-04-19 | Chinese | ||
| 39155053 | 关于召开2025年年度暨2026年第一季度业绩说明会的公告 | 2026-04-19 | Chinese | ||
| 39155051 | 2025年度董事会审计委员会履职报告 | 2026-04-19 | Chinese | ||
| 39155050 | 关于2025年度利润分配方案及2026年中期分红规划的公告 | 2026-04-19 | Chinese | ||
| 39155037 | 杭州奥泰生物技术股份有限公司二〇二五年度审计报告 | 2026-04-19 | Chinese | ||
| 39154425 | 关于杭州奥泰生物技术股份有限公司非经营性资金占用及其他关联资金往来的专项说明 | 2026-04-19 | Chinese | ||
| 39154420 | 2026年第一季度报告 | 2026-04-19 | Chinese | ||
| 39154410 | 2025年年度报告 | 2026-04-19 | Chinese | ||
| 39154408 | 关于公司2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-19 | Chinese | ||
| 39154405 | 董事会关于独立董事独立性情况的专项意见 | 2026-04-19 | Chinese | ||
| 39154402 | 2025年年度报告摘要 | 2026-04-19 | Chinese | ||
| 39154399 | 2025年度可持续发展报告暨环境、社会及公司治理（ESG）报告 | 2026-04-19 | Chinese | ||
| 39154393 | 2026年度''''提质增效重回报”行动方案 | 2026-04-19 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
HANGZHOU ALLTEST BIOTECH CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58528/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58528 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58528 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58528 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58528}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HANGZHOU ALLTEST BIOTECH CO.,LTD. (id: 58528)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.